Ultrasound- Guided Continuous Retro Laminar Block Versus Continuous Erector Spinae Plane Block in Multiple Rib Fractures
Conditions: Retrolaminar Block; Erector Spinae Plane Block; Spirometry; Pain; Multiple Rib Fractures Interventions: Drug: Retrolaminar block group; Drug: Erector spinae plane block group. Sponsors: Tanta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
DiscussionRobust data concerning the possible long-term benefits of prophylactic LISA treatment are lacking. The current observational data from the German Neonatal Network indicate that approximately 50% of preterm infants with supplemental oxygen at or below 30% within the first hour of life are treated with LISA. The pro.LISA trial will provide short- and long-term outcomes of preterm infants receiving prophylactic treatment and will clarify if prophylactic treatment should be given to all preterm infants or if the current practice of selective treatment if supplemental oxygen exceeds 30% is more appropriate.Trial regis...
Source: Trials - September 26, 2023 Category: Research Source Type: clinical trials
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Condition: Asthma Interventions: Drug: Mepolizumab; Other: Spirometry Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Quality Improvement Project of Nurse Guiding Incentive Spirometry After Cardiac Surgery
Conditions: Lung Expansion Therapy; Post-cardiac Surgery Intervention: Behavioral: on-the-job training of lung expansion therapy Sponsor: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Condition: Asthma Interventions: Drug: Mepolizumab; Other: Spirometry Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Quality Improvement Project of Nurse Guiding Incentive Spirometry After Cardiac Surgery
Conditions: Lung Expansion Therapy; Post-cardiac Surgery Intervention: Behavioral: on-the-job training of lung expansion therapy Sponsor: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Condition: Asthma Interventions: Drug: Mepolizumab; Other: Spirometry Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Quality Improvement Project of Nurse Guiding Incentive Spirometry After Cardiac Surgery
Conditions: Lung Expansion Therapy; Post-cardiac Surgery Intervention: Behavioral: on-the-job training of lung expansion therapy Sponsor: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Condition: Asthma Interventions: Drug: Mepolizumab; Other: Spirometry Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Quality Improvement Project of Nurse Guiding Incentive Spirometry After Cardiac Surgery
Conditions: Lung Expansion Therapy; Post-cardiac Surgery Intervention: Behavioral: on-the-job training of lung expansion therapy Sponsor: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Condition: Asthma Interventions: Drug: Mepolizumab; Other: Spirometry Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Quality Improvement Project of Nurse Guiding Incentive Spirometry After Cardiac Surgery
Conditions: Lung Expansion Therapy; Post-cardiac Surgery Intervention: Behavioral: on-the-job training of lung expansion therapy Sponsor: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Condition: Asthma Interventions: Drug: Mepolizumab; Other: Spirometry Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Quality Improvement Project of Nurse Guiding Incentive Spirometry After Cardiac Surgery
Conditions: Lung Expansion Therapy; Post-cardiac Surgery Intervention: Behavioral: on-the-job training of lung expansion therapy Sponsor: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Condition: Asthma Interventions: Drug: Mepolizumab; Other: Spirometry Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
